Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: IPEX Study: Pancreatic Exocrine Insufficiency as a Functional Marker of Disease Progression in Patients With IPMN

View source ↗

Summary

This clinical trial update describes the IPEX study, which investigates pancreatic exocrine insufficiency as a functional marker of disease progression in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: A.O.U. Città della Salute e della Scienza | Conditions: Intraductal Papillary Mucinous Neoplasms, Pancreatic Exocrine Insufficiency | Status: NOT_YET_RECRUITING